首页>European Journal of Haematology>Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: Implications for prophylaxis
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: Implications for prophylaxis
作者单位：Department of Medicine, University of Melbourne, Parkville, VIC, Australia, Department of[1]Department of Infectious Diseases and Infection Control, Peter MacCallum Cancer Centre, East[2]Pharmacy Department, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia[3]Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia[4]
换一批
换一批
